Page last updated: 2024-09-05

muraglitazar and corticosterone

muraglitazar has been researched along with corticosterone in 1 studies

Compound Research Comparison

Studies
(muraglitazar)
Trials
(muraglitazar)
Recent Studies (post-2010)
(muraglitazar)
Studies
(corticosterone)
Trials
(corticosterone)
Recent Studies (post-2010) (corticosterone)
85102527,1211246,622

Protein Interaction Comparison

ProteinTaxonomymuraglitazar (IC50)corticosterone (IC50)
Solute carrier family 22 member 3Homo sapiens (human)0.945
Solute carrier family 22 member 3Rattus norvegicus (Norway rat)4.9
Solute carrier family 22 member 2Rattus norvegicus (Norway rat)4.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biller, S; Cap, M; Chen, S; Cheng, PT; Chu, C; Devasthale, P; Farrelly, D; Fenderson, W; Gregg, R; Gu, L; Hariharan, N; Harrity, T; Jeon, Y; Kunselman, L; Mookhtiar, KA; Ponticiello, R; Qu, F; Ren, J; Ryono, D; Seethala, R; Shao, C; Tieman, A; Wang, W; Wetterau, J; Yang, WP; Zhang, H; Zhou, M1

Other Studies

1 other study(ies) available for muraglitazar and corticosterone

ArticleYear
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Diabetes, 2006, Volume: 55, Issue:1

    Topics: Adiponectin; Animals; Blood Glucose; Corticosterone; Diabetes Mellitus, Type 2; Diet; Female; Glycine; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Liver; Mice; Obesity; Oxazoles; Peroxisome Proliferator-Activated Receptors; Rosiglitazone; Thiazolidinediones

2006